Ambalal Sarabhai Enterprises Ltd


BSE: 500009 | NSE: AMBASARABH | ISIN: INE432A01017 
Market Cap: [Rs.Cr.] 19 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Formulations

 Discuss this stock

Balance Sheet

(Rs. in Crores)
ParticularsMar-12Mar-11Mar-10Mar-09Mar-08Mar-07
SOURCES OF FUNDS :      
Share Capital 76.6376.6376.6376.6376.6376.63
Reserves Total -26.16-19.30-17.92-19.71-30.18-21.88
Total Shareholders Funds50.4757.3358.7156.9246.4554.75
Secured Loans 8.687.415.784.1612.2838.73
Unsecured Loans 8.205.842.620.8925.5731.82
Total Debt16.8813.258.405.0537.8570.55
Total Liabilities67.3570.5867.1161.9784.30125.30
APPLICATION OF FUNDS :      
Gross Block 99.63100.21109.00110.05141.38146.51
Less : Accumulated Depreciation 39.6037.9944.0841.9856.3455.34
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 60.0362.2264.9268.0785.0491.17
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress0.100.430.850.680.250.13
Investments 58.4956.9444.1641.1041.1268.16
Current Assets, Loans & Advances      
Inventories 1.620.887.268.2611.1912.96
Sundry Debtors 3.6015.2718.1622.6336.2631.18
Cash and Bank0.641.1213.9411.3210.686.84
Loans and Advances 27.6234.4753.1419.34122.52122.01
Total Current Assets33.4851.7492.5061.55180.65172.99
Less : Current Liabilities and Provisions      
Current Liabilities 81.1787.7480.5996.23172.35156.00
Provisions 2.7813.2954.7313.2050.4151.15
Total Current Liabilities83.95101.03135.32109.43222.76207.15
Net Current Assets-50.47-49.29-42.82-47.88-42.11-34.16
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets0.000.000.000.000.000.00
Deferred Tax Liability0.000.000.000.000.000.00
Net Deferred Tax0.000.000.000.000.000.00
Total Assets68.1570.3067.1161.9784.30125.30
Contingent Liabilities443.65403.76415.6428.5026.9219.28

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Ajanta Pharma 2,220.35 21.96 6.23 5.40 27.3 24.2 0.72
Plethico Pharma. 697.24 60.55 1.27 33.34 -5.5 3.8 1.08
Sharon Bio-Med. 361.89 7.02 1.98 9.58 19.1 14.1 1.85
Bliss GVS Pharma 306.72 5.23 1.46 2.15 28.0 42.7 0.04
Venus Remedies 292.27 5.11 0.75 3.54 17.7 16.9 0.72
Kappac Pharma 271.33 0.00 11.31 0.00 0.0 0.0 0.06
Parenteral Drugs 262.19 0.00 1.04 58.93 -16.1 -0.7 0.86
Ahlcon Parent(I) 247.72 19.24 4.58 22.59 12.6 17.0 0.59
Syncom Formul. 246.86 70.96 2.95 13.86 4.3 6.7 0.09
Amrutanjan Healt 192.14 16.35 1.93 9.89 12.6 16.3 0.23
Arvind Remedies 154.34 3.80 1.14 6.60 15.1 16.1 2.12
Combat Drugs 105.96 0.00 18.32 0.00 0.3 0.3 0.07
Zenotech Lab. 103.29 0.00 2.00 0.00 0.0 0.0 0.08
Hester Bios 94.46 11.62 1.57 4.56 14.4 20.6 0.35
Caplin Point Lab 93.68 6.03 3.09 1.38 29.3 33.1 0.30

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Kartikeya V Sarabhai , Chairman & Wholetime Director 

B S Bohra , Director 

B V Suryakumar , Director 

Govind Das Zalani , Director 


Company Head Office / Quarters:
Sarabhai Campus,
Gorwa Road,
Vadodara,
Gujarat-390023
Phone :
Fax :
E-mail : ddesai@sarabhai.co.in
Web : http://
Registrars:
MCS Limited
Neelam Apt 88
Sampat Rao Colony
Po Race Course
Vadodara 390007

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Open : India Finsec
Economic Events
list Bank of Japan April 26 meeting minutes
list BOJ Governor Kuroda Speech in Tokyo
Results
list No result today